24 June 2026
Latham & Watkins Advises Boundless Bio on Merger With Serapha Bio
Advising firms
Deal team
29 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Daniel Rees Lead | Latham & Watkins LLP | Partner | corporate | Not stated |
| Cheston Larson Lead | Latham & Watkins LLP | Partner | corporate | Not stated |
| Matt Bush Lead | Latham & Watkins LLP | Partner | corporate | Not stated |
| Shannon Cheng Lead | Latham & Watkins LLP | Partner | corporate | Not stated |
| Dylan Towns | Latham & Watkins LLP | Associate | corporate | Not stated |
| Amy Lutfi | Latham & Watkins LLP | Associate | corporate | Not stated |
| Ashley Campfield | Latham & Watkins LLP | Associate | corporate | Not stated |
| Joanna Yam | Latham & Watkins LLP | Associate | corporate | Not stated |
| Emily Okabe | Latham & Watkins LLP | Associate | corporate | Not stated |
| Nadia Patiño | Latham & Watkins LLP | Associate | capital markets | Not stated |
| Shelby Harrison | Latham & Watkins LLP | Associate | capital markets | Not stated |
| Sterling Swift | Latham & Watkins LLP | Associate | capital markets | Not stated |
| Betty Pang | Latham & Watkins LLP | Partner | FDA and healthcare regulatory | Not stated |
| Chad Jennings | Latham & Watkins LLP | Counsel | FDA and healthcare regulatory | Not stated |
| Evan Miller | Latham & Watkins LLP | Associate | FDA and healthcare regulatory | Not stated |
| Steven Chinowsky | Latham & Watkins LLP | Partner | intellectual property | Not stated |
| Robert Yeh | Latham & Watkins LLP | Counsel | intellectual property | Not stated |
| Patrick Chew | Latham & Watkins LLP | Associate | intellectual property | Not stated |
| Eric Cho | Latham & Watkins LLP | Partner | tax | Not stated |
| Chris Zhao | Latham & Watkins LLP | Associate | tax | Not stated |
| Holly Bauer | Latham & Watkins LLP | Partner | benefits and executive compensation | Not stated |
| James Robinson | Latham & Watkins LLP | Partner | benefits and executive compensation | Not stated |
| Julie Voorhes | Latham & Watkins LLP | Associate | benefits and executive compensation | Not stated |
| Genie Yae | Latham & Watkins LLP | Associate | benefits and executive compensation | Not stated |
| Patrick English | Latham & Watkins LLP | Partner | antitrust | Not stated |
| Kyra Bromley | Latham & Watkins LLP | Partner | antitrust | Not stated |
| Suhansi Perera | Latham & Watkins LLP | Associate | antitrust | Not stated |
| Heather Deixler | Latham & Watkins LLP | Partner | data privacy and cybersecurity | Not stated |
| Zac Alpert | Latham & Watkins LLP | Associate | data privacy and cybersecurity | Not stated |
26 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 230m (approximately US$230 million)
- What the figure measures
- Not stated
- Client
- Boundless Bio, Inc.Buy-side
- Counterparties
- Serapha Bio, Inc. (Sell-side)